Arkolith/Insider Trading/LSTA/Form 4

Mazzo David J

Chief Executive Officer, DirectorLISATA THERAPEUTICS, INC. (LSTA) · full profile →Form 4 · filed Jan 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 10, 2023Tax withholding(F)3K$3.20$11K98K
Jan 9, 2023Tax withholding(F)8K$3.00$24K101K
Jan 9, 2023Grant(A)60K—$0109K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 9, 2023Grant(A)30K—$030K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001334549-23-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML